Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Members of Congress who traded ORMP
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 4
- Filings
- 4
- Members
- 2
- Buys / sells
- 1 / 3
- Estimated volume
- $56.5K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Brad KnottRepublican · House · NC | 1 | 0 / 1 | $32.5K | Jan 10, 2025 | Feb 25, 2025 |
| Andrew R. GarbarinoRepublican · House · NY | 3 | 1 / 2 | $24.0K | Jan 14, 2022 | Jan 14, 2022 |
Trades
Every reported trade in Oramed Pharmaceuticals Inc., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Brad KnottRepublican · House · NC | ORMPOramed Pharmaceuticals Inc. - Common Stock | Sell | Self | Jan 10, 2025 | Feb 25, 2025 | 46 daysLate | $15K-$50K | Filing |
| Andrew R. GarbarinoRepublican · House · NY | ORMPOramed Pharmaceuticals Inc. | Sell | Self | Jan 14, 2022 | Jan 14, 2022 | Same day | $1K-$15K | Filing |
| Andrew R. GarbarinoRepublican · House · NY | ORMPOramed Pharmaceuticals Inc. | Sell (partial) | Self | Oct 1, 2021 | Nov 3, 2021 | 33 days | $1K-$15K | Filing |
| Andrew R. GarbarinoRepublican · House · NY | ORMPOramed Pharmaceuticals Inc. | Buy | Self | Apr 23, 2021 | May 24, 2021 | 31 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.